uBriGene Biosciences completes several hundred million yuan Series C round funding
uBriGene Biosciences completes several hundred million yuan Series C round funding, focusing on global cell & gene therapy and...
uBriGene Biosciences completes several hundred million yuan Series C round funding
Correcting visual impairment: VGR-R01 project IND application accepted by Center for Drug Evaluation
Assisted Clinical Application of Gene Therapy for Hemophilia B of Vitalgen Accepted by NMPA
Assisted Clinical Application of Gene Therapy in Ophthalmology of Innostellar Accepted by NMPA